VanEck Associates
CRL icon

VanEck Associates’s Charles River Laboratories CRL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.76M Sell
44,526
-1,724
-4% -$262K 0.01% 612
2025
Q1
$6.96M Sell
46,250
-2,130
-4% -$321K 0.01% 594
2024
Q4
$8.93M Sell
48,380
-2,893
-6% -$534K 0.01% 498
2024
Q3
$9.57M Sell
51,273
-6,633
-11% -$1.24M 0.01% 455
2024
Q2
$12M Buy
57,906
+2,269
+4% +$469K 0.02% 376
2024
Q1
$15.1M Sell
55,637
-2,042
-4% -$553K 0.02% 321
2023
Q4
$13.6M Sell
57,679
-5,418
-9% -$1.28M 0.02% 309
2023
Q3
$12.4M Buy
63,097
+7,461
+13% +$1.46M 0.03% 313
2023
Q2
$11.7M Buy
55,636
+2,387
+4% +$502K 0.03% 321
2023
Q1
$10.7M Sell
53,249
-7,950
-13% -$1.6M 0.02% 337
2022
Q4
$13.3M Buy
61,199
+15,893
+35% +$3.46M 0.03% 293
2022
Q3
$8.92M Sell
45,306
-15,778
-26% -$3.11M 0.03% 333
2022
Q2
$13.1M Buy
61,084
+4,305
+8% +$921K 0.03% 291
2022
Q1
$16.1M Buy
56,779
+253
+0.4% +$71.8K 0.03% 289
2021
Q4
$21.3M Sell
56,526
-4,076
-7% -$1.54M 0.05% 246
2021
Q3
$25M Sell
60,602
-11,399
-16% -$4.7M 0.06% 225
2021
Q2
$26.6M Buy
72,001
+5,757
+9% +$2.13M 0.06% 223
2021
Q1
$19.2M Sell
66,244
-5,255
-7% -$1.52M 0.05% 235
2020
Q4
$17.9M Buy
71,499
+6,915
+11% +$1.73M 0.05% 218
2020
Q3
$14.6M Sell
64,584
-13,522
-17% -$3.06M 0.05% 215
2020
Q2
$13.6M Buy
78,106
+17,569
+29% +$3.06M 0.05% 217
2020
Q1
$7.64M Sell
60,537
-15,455
-20% -$1.95M 0.04% 254
2019
Q4
$11.6M Buy
75,992
+1,016
+1% +$155K 0.04% 235
2019
Q3
$9.93M Buy
74,976
+1,814
+2% +$240K 0.05% 220
2019
Q2
$10.4M Sell
73,162
-13,803
-16% -$1.96M 0.05% 223
2019
Q1
$12.6M Sell
86,965
-13,974
-14% -$2.03M 0.06% 200
2018
Q4
$11.4M Buy
100,939
+6,782
+7% +$768K 0.06% 213
2018
Q3
$12.7M Buy
94,157
+481
+0.5% +$64.7K 0.06% 225
2018
Q2
$10.5M Buy
93,676
+13,291
+17% +$1.49M 0.05% 230
2018
Q1
$8.58M Sell
80,385
-19,168
-19% -$2.05M 0.04% 242
2017
Q4
$10.9M Sell
99,553
-53,924
-35% -$5.9M 0.05% 226
2017
Q3
$16.6M Buy
153,477
+5,195
+4% +$561K 0.08% 189
2017
Q2
$15M Buy
148,282
+17,097
+13% +$1.73M 0.08% 190
2017
Q1
$11.8M Buy
131,185
+7,228
+6% +$650K 0.05% 218
2016
Q4
$9.44M Sell
123,957
-753
-0.6% -$57.4K 0.05% 234
2016
Q3
$10.4M Sell
124,710
-18,872
-13% -$1.57M 0.05% 207
2016
Q2
$11.8M Buy
143,582
+16,186
+13% +$1.33M 0.06% 186
2016
Q1
$9.67M Buy
127,396
+7,389
+6% +$561K 0.07% 175
2015
Q4
$9.65M Buy
120,007
+3,253
+3% +$261K 0.08% 184
2015
Q3
$7.42M Sell
116,754
-18,947
-14% -$1.2M 0.06% 199
2015
Q2
$9.55M Buy
135,701
+11,542
+9% +$812K 0.06% 213
2015
Q1
$9.85M Buy
124,159
+113
+0.1% +$8.96K 0.06% 208
2014
Q4
$7.89M Buy
124,046
+4,483
+4% +$285K 0.05% 214
2014
Q3
$7.14M Sell
119,563
-6,511
-5% -$389K 0.04% 214
2014
Q2
$6.75M Sell
126,074
-28,760
-19% -$1.54M 0.03% 224
2014
Q1
$9.34M Buy
154,834
+25,451
+20% +$1.54M 0.05% 192
2013
Q4
$6.86M Buy
129,383
+13,052
+11% +$692K 0.03% 211
2013
Q3
$5.38M Buy
116,331
+2,075
+2% +$96K 0.03% 222
2013
Q2
$4.69M Buy
+114,256
New +$4.69M 0.03% 225